Tag: Cancer: Leukemia
iADL Dependency May Up Mortality in Hematologic Cancers
Instrumental activities of daily living dependency, mortality linked in seniors with hematologic cancer
Reasons for TKI Discontinuation ID’d in Chronic Myeloid Leukemia
Treatment-free remission maintained in 14 of 21 patients who discontinued tyrosine kinase inhibitors
Presence of Leukemia Cutis Tied to Worse Survival in AML
Hazard ratios for leukemia-specific death, all-cause death higher for patients with AML and LC
Population Mortality Affects Long-Term Follow-Up of AlloHCT
Substantial part of total nonrelapse mortality for older patients due to population mortality
AACR: Longer Survival With Gilteritinib in FLT3mut+ AML
Longer overall survival, better remission rates seen for patients receiving gilteritinib versus salvage chemo
Favorable Outcomes Seen in Long Term for ALLR3 Trial
Findings for risk-stratified tx in B-cell precursor acute lymphoblastic leukemia, late bone marrow relapse
Only About Half of Elderly Newly Diagnosed With ALL Receive Tx
53.5 percent receive treatment within 90 days; 32.4 percent receive chemo without tyrosine kinase inhibitors
Genetic Variant Tied to Leukemia Risk in Hispanic Children
Novel susceptibility locus identified in the ERG gene for acute lymphoblastic leukemia
Obesity Linked to Adverse Events in Children With Leukemia
Obesity ups risk for treatment-requiring hypertension, insulin-requiring hyperglycemia
Addition of BMT Not Indicated in Some With Peds Hypodiploid ALL
Bone marrow transplant not beneficial if no minimal residual dz after remission induction tx
